Fast Facts
#5
in NIH Funding
Top Ranked
consistently ranked a top tier residency program
30+
active clinical trials
Comprehensive patient care
National leaders in every subspecialty offer personalized, team-based care for the full range of adult and pediatric neurosurgical conditions.
Showing: All results
Commitment to innovation
Our rare focus on innovation and technology allows us to offer patients the very latest advances and optimal treatments — many developed by our own highly skilled surgeons.
Need to make an appointment?
Offering in-person visits at nine convenient locations.
Excellence in education
Our seven-year residency and one-year fellowship prepare trainees for successful careers in academic neurosurgery.
- Mentorship from pioneers in the field
- Extraordinary research opportunities
- High-volume, comprehensive clinical practice
- Collaborative, inclusive culture
Our pioneering research fuels advances that improve and save lives.
News
Researchers make glioblastoma cells visible to attacking immune cells
Strategy involves placing targets on deadly cancer’s cells, potentially making them vulnerable to immunotherapies By: Julia Evangelou Strait Even treated with the most advanced therapies, patients with glioblastoma — an aggressive brain cancer — typically survive less than two years after diagnosis. Efforts to treat this cancer with the latest immunotherapies have been unsuccessful, likely […]
This is(n’t) Cancer: Advances Against Brain Tumors, Benign or Not
After minor blurred vision prompted Ellen to get an eye exam, she was surprised to learn she had a mass in the middle of her brain near the nerve connected to her left eye. A referral to Siteman quickly led to the diagnosis of a brain tumor. Fortunately, it was noncancerous and had a surgical […]
Study increases understanding of why recurrent meningiomas are aggressive
By: Graciela GutierrezArticle originally appeared in Baylor College of Medicine News Researchers at Baylor College of Medicine and Washington University School of Medicine in St. Louis have identified clinical and genetic predictors of multiply recurrent meningiomas (MRMs), a most aggressive form of this common brain tumor. Published in Science Advances, the study opens new opportunities for […]